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Abstract
A common approach for developing diagnostic tests for influenza virus detection is the use
of mouse or rabbit monoclonal and/or polyclonal antibodies against a target antigen of the
virus. However, comparative mapping of the target antigen using antibodies from different
animal sources has not been evaluated before. This is important because identification of
antigenic determinants of the target antigen in different species plays a central role to
ensure the efficiency of a diagnostic test, such as competitive ELISA or immunohistochem-
istry-based tests. Interest in the matrix 2 ectodomain (M2e) protein of avian influenza virus
(AIV) as a candidate for a universal vaccine and also as a marker for detection of virus infec-
tion in vaccinated animals (DIVA) is the rationale for the selection of this protein for compar-
ative mapping evaluation. This study aimed to map the epitopes of the M2e protein of avian
influenza virus H5N1 using chicken, mouse and rabbit monoclonal or monospecific antibod-
ies. Our findings revealed that rabbit antibodies (rAbs) recognized epitope 6EVETPTRN13
of the M2e, located at the N-terminal of the protein, while mouse (mAb) and chicken antibod-
ies (cAbs) recognized epitope 10PTRNEWECK18, located at the centre region of the protein.
The findings highlighted the difference between the M2e antigenic determinants recognized
by different species that emphasized the importance of comparative mapping of antibody
reactivity from different animals to the same antigen, especially in the case of multi-host
infectious agents such as influenza. The findings are of importance for antigenic mapping,
as well as diagnostic test and vaccine development.
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Introduction
Matrix protein 2 (M2) of avian influenza virus (AIV) is a 97 amino acids (aa) protein encoded
by RNA segment 7 of the influenza A virus (IAV) [1]. It is translated from spliced mRNA and
shares a common start codon with the matrix 1 (M1) protein and the first nine aa, while the
remaining 88 aa continues at the second (+1) open reading frame [1, 2]. In its native state, M2
is a homotetrameric type III integral membrane protein composed of three domains; namely, a
54 aa cytoplasmic domain located in the viral envelope or cytoplasmic membrane of infected
cells, a 19 aa transmembrane domain, and an N-terminal 24 aa ectodomain (M2e) which is
exposed on the surface of the virus infected cells and on the viral particles [1, 3–5]. In the
infected cell the M2 protein forms an ion channel which is vital for viral genome delivery into
the host cell during virus entry [2, 3, 5–8]. Briefly, M2 ion channel activity is activated by acidi-
fication of virus-containing endosomes after internalization of the virus particle into the host
cell via clathrin-dependant and –independent mechanisms [9, 10].
Amino acids 1–9 of the M2e protein are highly conserved across AIV strains, while minimal
aa variation is observed for residues 10 to 24, making it an attractive target for AIV universal
vaccine development [2, 11–20]. The M2e protein is low in copy number on the virus particle,
but it is abundantly expressed on the surface of an infected cells [3, 21]. This differential epi-
tope density between infected cells (high) and a mature virion (low) [15, 22] is the key feature
for its recommendation as a marker for differentiating infected animals in vaccinated popula-
tion (DIVA), a strategy used in AIV surveillance [23, 24].
The sensitivity and specificity of M2e-based DIVA have been demonstrated in our previous
works [25–27]. This raised our interest towards the potential use of M2e in a competitive
enzyme-linked immunosorbent assay (ELISA) format as a surveillance tool for AIV infection.
The principle of competitive ELISA lies in the ability of the test subject antibody (e.g. chicken)
to inhibit competitor antibodies, usually produced in rabbit or mouse, from binding to the tar-
get antigen. Hence, it is important for the competitor antibodies to react with the same viral
epitopes as the antibodies produced by the test species. Such an ELISA format has been suc-
cessfully demonstrated for the nucleoprotein of AIV, which has been proven to be reliable and
applicable for multispecies surveillance [28–30]. However, M2e-based competitive ELISA is a
better alternative DIVA test for an AIV surveillance tool, especially in the highly pathogenic
AIV H5N1 endemic countries, where poultry vaccination using inactivated AIV is practiced.
It is accepted that due to differences in the germline gene repertoire in different species,
accompanied by distinct mechanisms for generation and affinity maturation of antibodies,
antigenic determinants recognized by a host can vary from one species to another [31–33]. Ear-
lier studies on M2e protein for vaccine development have reported several antigenic determi-
nants identified by anti-M2e antibodies isolated from rabbit, mouse and human [20, 34, 35]. In
most cases, the M2e epitopes recognized were located in the region that span from the N-termi-
nal to the middle region of M2e, and vary in length from 5 residues (2SLLTE6) [35], up to 15
residues 2SLLTEVETPIRNEWG16 [20, 34]. Here, we describe epitope mapping using anti-M2e
antibodies from chicken, mouse and rabbit to identify the M2e antigenic determinants for each
antibody group, and to assess the most suitable animal source of anti-M2e antibodies in M2e-
based competitive ELISA as an advanced DIVA test for H5N1 infections in poultry.
Material & Methods
Peptides for mouse and rabbit immunization and antigenic mapping
Peptide immunization for mouse and rabbit was done using the 17 amino acid (aa) M2e pep-
tide (M2e2-18), corresponding to residues 2 to 18 of HPAIV H5N1 Indonesian strain A/
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Chicken/West Java/PWT-WIJ/2006, (2SLLTEVETPTRNEWECK18) [25–27]. It was conju-
gated with Keyhole Limpet Hemocyanin (M2e-KLH) at the C-terminal end for the anti-M2e
antibodies production in mice (Abmart, Shanghai, China) and rabbits (Peptide 2, Chantilly,
Virginia, USA).
M2e-mapping was done using two sets of overlapping short peptides spanning M2e2-24. Set
1 included eight peptides of 9–10 aa length (WatsonBio, Houston, Texas) with two aa offsets
each; while set 2 included three peptides of 14 aa length (Abmart, Shanghai, China) with three
aa offsets each (Table 1). M2e2-18 was used for anti-M2e antibodies screening in indirect
ELISA, as well as the positive antigen control in mapping ELISA, instead of M2e2-24, as both
showed similar reactivity in previous study [26]. All peptides used were of>90% purity as
determined by high performance liquid chromatography analyses.
Antibodies (sera)
Three different sources of anti-M2e antibodies were used in this study, namely chicken poly-
clonal antibodies (cAbs), mouse monoclonal antibodies (mAbs), and rabbit polyclonal anti-
bodies (rAbs) (Table 2). CAbs were produced as described previously [25, 27]. In brief,
commercial layer chicks were inoculated with inactivated H5N1 AI vaccine (Medivac-AI, PT
Medion, Bandung, Indonesia), once (16 weeks of age), twice (12 and 16 weeks of age) or three
times (8, 12 and 16 weeks of age). All chicks were challenged with live H5N1 strain (either A/
Ck/West Java/PWT-WIJ/2006, or A/Ck/West Java/Sbg-29/2007) two weeks after the last vacci-
nation. All challenge experiments were conducted in the Biosecurity level 3 (BSL3) facilities at
the Indonesian Research Centre for Veterinary Science, Bogor, Indonesia. Collected sera were
tested for M2e reactivity using indirect M2e ELISA [25, 26]. Reference H5N1 sera (A/Chicken/
Scotland/59) was obtained from the Veterinary Laboratory Agency (New Haw, Addlestone,
UK) as described previously [26].
Hybridoma cells producing anti-M2e mAbs were produced by Abmart (Shanghai, China)
following immunization of mice with M2e(2–19)-KLH peptide. Briefly, six female BALB/c mice
were injected subcutaneously at multiple sites with an emulsion contained 0.05 mg KLH-M2e
peptide mixed with complete Freund’s adjuvant (CFA). Immunization was done four times 14
days apart. Booster injections were given 14 days after last immunization with 0.05 mg
KLH-M2e peptide in incomplete Freund’s adjuvant (IFA). Serum sampling was done seven
days after the third and fourth immunization and sera tested for anti-M2e antibodies using
Table 1. Overlapping peptides covering the full length H5N1M2e protein (M2e2-24), designed with 10 amino acid (aa) with 2 offsets, and 14 aa with
3 offsets each. Peptide M2e2-18 was used as a control antigen in place of M2e2-24.
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indirect M2e-ELISA. Fusion of myeloma cells and spleen cells was followed by another indirect
M2e-ELISA screening. Selected clones of hybridoma cells were expanded and grown in Dulbec-
co’s modified Eagles medium (DMEM) high glucose with L-glutamine (HyClone, GE Health-
care) with 15% foetal bovine serum (HyClone, GE Healthcare) and 1% (v/v) penicillin and
streptomycin (Gibco, Thermofisher Scientific). MAb supernatants from cell culture were col-
umn purified using Pierce Recombinant Protein A Agarose (Thermofisher Scientific). No sig-
nificant difference was observed between the column purified and precipitated mAb in indirect
ELISA. Thus, for the experiments described here, the mAb supernatants were precipitated
using 50% saturated solution of ammonium sulphate and the protein pelleted was resuspended
in sterile phosphate saline buffer (PBS) and stored at -20°C until required.
Eight New Zealand White rabbits with the average age of 6 months were chosen to obtain
hyperimmune serum against the M2e peptide. Rabbits were inoculated at five subcutaneous
sites with an emulsion that contained 0.1 mg of KLH-M2e peptide mixed with CFA. The rab-
bits received booster injections containing 0.1 mg KLH-M2e peptide in IFA at day 14 and 28.
Blood was collected two weeks after the final immunization and antisera tested using indirect
M2e-ELISA.
Indirect M2e-ELISA and antigenic mapping
All peptides were dissolved in diethylpyrocarbonate (DEPC)-treated water (Bioline) to a final
concentration of 1 mg/ml. Peptides were diluted with 0.1 M carbonate-bicarbonate buffer, pH
9.6 (0.1 M Na2CO3, 0.1 M NaHCO3) to the final concentration of 10 μg/ml, and 100 μl was
added to each well of a 96-well flat bottom microtiter plate (Maxisorp, NUNC) and incubated
at 4°C overnight. The coated plates were washed five times with PBS containing 0.05% Tween
20 (PBS-T) and blocked with 2% BSA in PBS (200 μl/ well) for 2 hrs at room temperature (RT).
Table 2. Antibody types and animals used for the generation of antibodies either by H5N1 virus challenge, or KLH-M2e2-19 peptide immunization.
Antibody type Antibody designation Immunogen
Chicken polyclonal antibodies PL64 A/Ck/West Java/PWT-WIJ/2006
PL80




Reference H5N1 sera A/Chicken/Scotland/59
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The chicken test sera were diluted with the high salt dilution buffer (HS-DB: 0.1 M Tris pH 7.4,
0.5 M NaCl, 1 mM Na2EDTA, 2% w/v BSA, 3% w/v Triton X-100, 3% w/v Tween 20) [25, 26],
and mouse and rabbit sera were diluted in PBS containing 1% BSA and 0.05% Tween 20
(PBS-BSA-T) with the dilution of 1:100 for all sera. The blocked plates were washed for five
times with PBS-T before the diluted serum was added into wells containing each peptide
(100 μl/well). After 1 hr of incubation at RT, the plates were subjected to another five rounds of
washing. Species-specific antibodies conjugated with horseradish peroxidase (HRP) enzymes
were prepared by dilution of anti-chicken HRP with HS-DB, and anti-mouse HRP (Sigma)
and anti-rabbit HRP were diluted with PBS-BSA-T. Diluted secondary antibodies were added
to each well (100 μl/well), followed by 1 hr incubation at RT. After washing, the substrate solu-
tion [100 μg/ml of tetramethylbenzidine substrate (TMB) (Sigma, St Louis, MO, USA)] in cit-
rate buffer (pH 8) containing hydrogen peroxide (100 μl of 0.6% H2O2) was added (100 μl/
well) and incubated at RT for 5–20 minutes before the reaction development was stopped with
stop buffer (1 M sulphuric acid) (50 μl/ well). The optical density (OD) of each well was deter-
mined at OD 450 nm using the BioRad Benchmark Plus Microplate Reader (BioRad, Hercules,
USA).
Statistical and bioinformatics analyses
Each antigenic peptide was tested in three dilutions with two replicas each. A range of univari-
ate and multivariate analyses were employed in this study as previously described [36], using
MINITAB 17 statistical package [37]. The mean OD450 values for the antigen negative wells
were subtracted from the mean OD450 values of antigen positive wells to get the corrected
OD450 values. One-way ANOVA and pair-wise mean comparison by Tukey test was used to
compare the corrected ELISA values of different antigenic peptides within each type of anti-
body (chicken, mouse, and rabbit). Antibody reactivity to the M2e peptides was considered as
strong (>1.00), medium (0.50–1.00), weak (0.25–0.50) and negative (<0.20) in reference to its
OD450 value.
Clustering based on Average Linkage algorithm was used to illustrate the similarities/differ-
ences between different peptides in reaction with each type of antibody. The same method was
used to cluster antibodies against antigenic peptides. Hydrophobicity plot of M2e protein (aa
2–24) was constructed using the BioEdit software (North Carolina State University) and CLC
Genomics (QIAGEN) [38].
Ethics statement
Animal work carried out at the Indonesian Research Centre for Veterinary Science, Bogor,
Indonesia was approved by the Research Committee of Indonesian Research Centre for Veteri-
nary Science. The experimental chickens were handled by an expert veterinarian in animal
studies based on the guidelines of the National Health and Medical Research Council of Aus-
tralia. The animals were checked daily for clinical signs, morbidity, and mortality. All chickens
were bled via brachial vein and by cardiac puncture at the terminal step just after CO2 euthana-
sia. humane endpoint was not applied in this study.
Results
Chicken, mouse and rabbit antibodies selection using indirect-M2e
ELISA
Positive anti-M2e cAbs were selected based on findings from previous reports [25, 26], where
end-point HI antibody titers for all cAbs were approximately 1:512 dilutions (data not shown).
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Meanwhile, positive anti-M2e mAbs and rAbs showed ELISA titers between 1:1600 to 1:3200,
and 1:800 to 1:1600, respectively. As expected, comparison of mean OD450 readings for
chicken, mouse and most rabbit antibodies showed strong (OD450>1.0) reactivity to the
M2e2-18 (Table 3). All results for statistical analysis can be found in S1 File.
Chicken sera recognized at least 2 different epitopes spanning M2e
residue 5–18 and 10–17
M2e mapping ELISA results revealed a distinctive reactivity pattern between the chicken sera
exposed to the A/Ck/West Java/Sbg-29/2007 (Sbg-29/2007) (n = 4) and A/Ck/West Java/
PWT-WIJ/2006 (PWT/2006) (n = 2). Anti-M2e sera from chickens exposed to Sbg-29/2007
(2A17, 2B2, 2B47 and 2D10) showed a range of medium to strong reactivity to M2e8-21, strong
reactivity to M2e5-18 and weak to strong reactivity to M2e8-17 (Table 3). With the exception of
cAb 2B47, Sbg-29/2007 antisera also showed a range of weak to strong reactivity to M2e10-19.
Non-reactivity of cAb 2B47 to M2e10-19 was not fully understood, but this particular cAb was
only reactive to peptides which included residues E8 and T9 (Fig 1). Collectively, Sbg-29/2007
antisera showed reactivity to peptides which shared a minimum of eight residues (10PTRNE-
WEC17) of the M2e (Fig 1).
While Sbg-29/2007 antisera were reactive to peptides with 10 residues (M2e8-17 andM2e10-19),
as well as 14 residues (M2e5-18 andM2e8-21), chicken antisera to PWT/2006 (PL64 and PL80)
were only reactive to the 14 residues M2e5-18 (Table 3). Despite M2e5-18 sharing residues with the
whole M2e6-15 andM2e8-17, and most residues inM2e4-13 and M2e10-19, neither of the PWT/
2006 antisera reacted to any of these shorter peptides. This suggested that these 10-residue pep-
tides were inadequate to represent the PWT/2006-strain epitope which elicited antibody
responses in the chickens.
Although the reference H5N1 serum (produced against A/chick/Scotland/59 strain) was
commercially generated based on its hemagglutinin inhibition titer, it showed strong reactivity
to peptide M2e2-18 (mean OD450 2.02) (Table 3). However, no reactivity was observed between
the reference sera and any of the mapping peptides. Alignment of the peptides recognized by
the chicken sera showed that at least two epitopes, in addition to the immunogen, were recog-
nized, namely M2e5-18 (
5TEVETPTRNEWECK18) and M2e10-18 (
10PTRNEWECK18) (Table 3,
Fig 2). Both epitopes contained residues M2e 10–17, which are recognised by all cAbs and
which correspond to the most hydrophilic part of the M2e protein (residues 12 to 20) (Fig 2).
Chicken sera reactivity pattern is highly influenced by its immunogen as
well as individual chicken immune response
Clustering analysis of chicken antisera based on their reactivity with M2e peptides revealed two
major clusters broadly related to the antigen used to immunise the donor chickens (Fig 3). Clus-
ter 1 grouped Sbg-29/2007 antisera together, particularly 2B2, 2A17 and 2B47, based on their
reactivity to M2e8-17, 10–19, 5–18, 8–21 and M2e2-18; while cluster 2 grouped PWT/2006 antisera
(PL64 and PL80), based on their reactivity to M2e5-18 and M2e2-18, along with the reference
H5N1 sera (produced against A/chick/Scotland/59) which only reacted to peptide M2e2-18.
Although cAb2D produced against the Sbg-29/2007 strain shared a similar reactivity pat-
tern with cAbs 2B2 and 2A17 (M2e8-17, 10–19, 5–18, 8–21 and M2e2-18), clustering analysis recog-
nized cAb 2D10 sera as the least similar to the other sera. Observation of its OD450 readings
showed that cAb 2D10 reacted strongly with all five peptides (OD450 2.02–2.33) (Table 3)
which was not observed with the other sera. And uniquely this sera also had high anti-M2e
antibodies titre (1:10,240).
Epitope Mapping of Avian Influenza M2e Protein
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Mouse monoclonal antibodies recognized epitopes M2e2-18 and M2e11-
18 while rabbit polyclonal antibodies recognized epitope M2e6-13
M2e comparative mapping by mAbs showed minimal variability in their reactivity patterns.
While all six mAbs strongly reacted with peptide M2e2-18 (OD450 1.69–3.30), only mAb 2E14
showed a weak and medium reactivity to M2e10-19 and M2e11-24, respectively (Table 3).
Together, mAbs recognized an M2e epitope containing a minimum of eight residues (11TRNE-
WECK18) to 17 residues (2SLLTEVETPTRNEWECK18), in which the epitopes mostly over-
lapped with the epitope recognized by cAbs described above (Fig 2).
Apart from the similar strong reactivity observed for peptide M2e2-18 (OD450 1.73), rAbs
also demonstrated strong reactivity to M2e4-13, M2e6-15 and M2e5-18 (Table 3), a combination
which was not demonstrated in the previous two groups of antibodies. All these peptides
shared residues 6EVETPTRN13 which indicated that the epitope recognized by rabbit was dif-
ferent from the chicken and mouse antibodies.
Comparison of the M2e epitopes recognized for all three groups of antibodies clearly
showed that the chicken, mouse and rabbit sera recognized five epitopes, namely M2e residues
2–18 for all antibodies, with specifically M2e residues 5–18 and 10–17 recognized by the cAbs,
Fig 1. Clustering based on average linkage algorithm illustrates the similarity of chicken antibodies reactivity to the M2e peptides as indicated
on the nodes of each group. Left to right: Cluster 1 (red box) chicken sera which reacted with M2e5-18 and M2e2-18; Cluster 2 (blue box) chicken sera
which reacted with M2e8-17, 10–19, 5–18, 8–21 and M2e2-18; and 2D10 chicken serum which reacted with M2e8-17, 10–19, 5–18, 8–21 and M2e2-18.
doi:10.1371/journal.pone.0156418.g001
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M2e residues 11–18 recognized by one mAb, and M2e residues 6–13 by the rAbs (Fig 2). The
shorter epitopes represented by the different antibodies group was recognized on two different
sites of the M2e protein. cAbs and mAbs antibodies recognized epitopes located at the central
region of the M2e protein (10PTRNEWECK18), while the rAb antibodies recognized an epitope
located at the N-terminal of the M2e protein (6EVETPTRN13) (Fig 2).
Fig 2. The antigenic determinants of M2e protein recognized by chicken, mouse and rabbit antibodies highlighted with the red boxes. In the
order from top to bottom, chicken antibodies to Sbg-29/2007 strain that recognized peptides containing residues 10PTRNEWEC17; chicken antibodies to
PWT/2006 strain recognized peptides with residues 5TEVETPTRNEWECK18; mouse monoclonal antibodies recognized peptides with residues
11TRNEWECK18 and rabbit antibodies recognized peptides with residues 6EVETPTRN13. Tested antibodies were listed on the left, while the peptides
corresponding to the residues recognized by each group are indicated on the right.
doi:10.1371/journal.pone.0156418.g002
Fig 3. Hydrophobicity plot of M2e protein sequence (residue 2 to 24) based on Kyte & Doolittle scale mean of hydrophobicity profile in
BioEdit.
doi:10.1371/journal.pone.0156418.g003
Epitope Mapping of Avian Influenza M2e Protein
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Discussion
Based on our previous success in demonstrating the effective use of M2e protein as a target for
DIVA strategy, we attempted to develop a competitive ELISA test targeting the M2e protein.
This test was anticipated to possess a broad host species applicability which is capable of DIVA
for a simple yet effective AIV surveillance tool in domestic poultry. We have here described the
comparative mapping of anti-M2e antibodies from chickens, mice and rabbits. Our findings
revealed the occurrence of two separate epitopes on the M2e protein, where one epitope was
exclusively recognized by the rAbs antibodies, while the other was recognized by both mAb
and cAbs. It is important to note that for development of a competitive ELISA, the test and
competitor antibodies need to cross-react with the same, or at least similar epitope, within the
same antigen. Such is the case where cAbs are the test antibodies, while mAbs but not rAbs are
the potential competitors.
Despite the difference in the immunogen used for anti-M2e antibody production in mice
and rabbits (KLH-conjugated peptide) versus chickens (H5N1 live virus), our findings that
cAbs, mAbs and rAbs recognized five M2e epitopes within the sequence 2SLLTEVETPTRNE-
WECK18 was similar to those of others [13, 14, 20, 34, 35, 39–45] (Table 4). The high frequency
of epitope 6EVETPTRN13 occurrence in the previous studies suggests that it is likely to be a
dominant epitope for M2e protein. Additionally, epitope 6EVETPTRN13 is potentially a major
epitope for rAbs, whereas a previous study on immunization of rabbits and mice using M2e2-10
2SLLTEVETP10 conjugated with KLH (SP1-KLH) showed to be more immunogenic in rabbits
than it was in mice [40].
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Difference at residue I11T between the current and previous studies corresponded to the human and swine speciﬁc M2e sequence in the former (I11) and
avian speciﬁc M2e sequence in the latter (T11) [57].
doi:10.1371/journal.pone.0156418.t004
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Minimal variation observed for mAbs was likely due to the double selection using M2e2-19-
KLH-based ELISA for hybridoma production and final selection. This limited the mAbs reac-
tivity only to the immunogen with low cross reactivity to the other peptides used in the study.
Nevertheless, one mAb recognized two other peptides which contain residues M2e 11–18
(Fig 2) that overlapped with M2e epitopes recognized for cAbs. Hence, mAb was suggested to
be a better competitor in a cELISA-based test for cAbs in contrast to rAbs, as the latter showed
fewer overlapping residues (Fig 2).
However, it was notable that one mAb and the majority of cAbs showed slight variation in
peptide recognition. Although the antigenic determinants recognized by the mAb and cAbs in
the current study overlapped with the epitopes found previously (residues 5 to 16 of M2e) [14,
20, 42–44], they differed in that two of the recognized epitopes (10PTRNEWEC17 for cAbs,
11TRNEWECK18 for mAb) extended further from the mid-region into the C-terminal end of
the M2e protein (Table 4). Both were shorter epitopes (8 aa in length) and independent of the
N-terminal peptide (M2e2-9), with one or two more residues at the epitope C-terminal (C17
and K18) than previously reported epitopes recognized in humans and mice. This suggests that
residues 2SLL4 is a less important antigenic determinant in chickens and rabbits than it is in
humans [35]. Conversely, C17 and K18 may possibly be important residues for cAbs epitope
recognition. Importance of K18 for mAb epitope recognition was also suggested by the
reported loss of anti-M2e antibody responses following immunization with truncated M2e2-16
in a vaccine study in mice [20]. Difference by two to three residues between the M2e epitopes
recognized by mAbs has also been described previously [43]. Zhang et al. (2006) suggested that
such observations could be due to either a true existence of species-related variation in epitope
recognition, or difference in assay sensitivity used for epitope recognition, or both [43]. Epitope
variation was observed in a separate M2e-unrelated study in rabbits using 10 human proteins,
where although the epitopes recognized for a single protein were similar, they were not identi-
cal [46]. The epitopes recognized by mAbs in the current study represent another species-
related variation of the existing recognized M2e epitopes, while this is the first known M2e epi-
tope reported in chickens. Nevertheless, M2e residue C17 and K18 may be of contributing to
the antigenic characteristics of M2e.
M2e protein residues S2, T5, E6, P10, I11, E14 and W15 have been identified as critical for
antibody interactions [34, 35, 44, 47–49]. Epitope studies have suggested that charged residues
(E, K an D), and polar residues (R, N, Q, P and T) are preferred in highly antigenic epitopes
[50, 51], where the hydrophilic amino acids (R, K, N, P, H, D and E) are more prominent [52].
A recent analysis of the M2e crystal structure complexed with monoclonal antibody has recog-
nized that residues T5, E6, V7, P10, R12 and N13 assist M2e hydrophilic interactions, which
contributes to epitope accessibility in antigen-antibody binding [47]. Amino acid variation at
residues P10, E14 and E16 resulted in predicted M2e structural differences between two H5N1
strains, Vietnam/1194/04 and Hong Kong/156/97 [53]. The latter H5N1 strain showed a folded
hairpin structure that limits antigen recognition in comparison to a relatively more accessible
structure observed in the former. M2e protein sequence is not available for PWT/2006 strain
used in current study. The M2e amino acid sequence of A/chick/Scotland/59 (EMBL accession
number CY015082) and A/Ck/West Java/Sbg-29/2007 (H5N1) (GenBank accession number
AKI82362.1) only differs by residue E14G for Scotland/59, and K18C for both from the M2e
A/Vietnam/1194/04, hence a similar ‘open’ structure is likely for the Sbg-29/2007 M2e protein.
It is noted that antibodies from chickens exposed to two different strains of H5N1 in current
study recognized two dominant but overlapping epitopes on the M2e protein. Differences
observed may be related to the M2e membrane-bound protein conformation of these two
H5N1 strains. Factors such as degree of protein protrusion from membrane surface [54], as
well as its accessibility for binding activities [55] highly influence the whole presentation of the
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protein to the birds immune system. Reactivity with only the 14 aa mapping peptide (M2e5-18,
5TEVETPTRNEWECK18) observed for sera PWT/2006 may be related to the structural ele-
ment formed by the protein on the virus particle. Previous study on the human tryptophanyl-
tRNA synthetase epitopes using 10 aa and 15 aa peptides has demonstrated similar observa-
tions [56]. It was suggested that the 10 aa peptides (M2e4-13, 6–15, 8–17 and 10–19) were not suffi-
cient to imitate the functional structure of the epitope since it is located in a loop structure
partially characterized by an α-helix. In the case of the M2e protein, its three-dimensional
structure showed a compact U-shaped conformation, where a β-turn structure is adopted by
residues T5 to E8, and 310 helix from residues I11 to W15 [47]. Hence, it was likely that
although the two epitopes residues overlap, the PWT/2006 sera were only reactive to the 14 aa
peptide M2e5-18 due to the lack of complete residue for a functional epitope formed by the 10
aa peptides.
Difference in length of recognized epitopes in anti-M2e cAbs may be related to the different
degree of virus virulence between the H5N1 strains and individual chicken immune responses.
Strong reactivity to the M2e peptides observed for the 2D chick sera in current study was rea-
soned to be due to the double boosts vaccination using killed virus, followed by a live virus
challenge. Current findings revealed that the Sbg-29/2007 antisera were capable of recognising
shorter epitopes in comparison to the PWT/2006 strain. Slight differences in signal intensity
for each identified peptide for Sbg-29/2007 antisera were also noted in relation to the number
of vaccinations for each individual birds. Previous study on epitope patterns in rabbit’s parallel
immunizations with a single antigen showed that polyclonal response in individual animal
may differs in their affinities [46]. Also, the difference in the immunogen used was implicated
in the lack of response to the mapping peptides observed for the reference H5N1 sera. Tempo-
ral and spatial distant origin of the strain used for immunisation (Scotland/59) from the strain
used as the basis for the mapping peptide design (PWT-WIJ//2006) has likely influenced this
particular cAb reactivity.
Although the relatively limited number of serum samples available for testing in the current
study do not represent the complexity of antibody response to M2e protein, nevertheless, the
results presented provided information on differences of Me2 epitope recognition by mouse,
rabbit and chicken antibodies. Identification of antigenic determinants or epitopes of the target
protein will enable us to formulate the most suitable source of anti-M2e antibodies for further
development.
In summary, we have identified five epitopes spanning residue 2 to 18 of M2e protein for
mouse, chicken and rabbit sera with variations in length (8 to 17 aa) from two localities on the
M2e protein (N-terminal and mid-region). We also concluded that mouse anti-M2e antibodies
are more suitable to be used as a competitor antibodies than the rabbit anti-M2e antibodies for
further work on M2e-based competitive ELISA diagnostic test. This was highly suggestive by
the overlapping epitopes (11TRNEWEC17) demonstrated by both chicken antibodies and one
of the mouse antibodies.
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